Inventor · disambiguated record
Hui Li
Also filed as: LI HUI · LI HUI JOYCE
41 granted patents·35 pending applications·109 citations·filing 1995–2025
96Inventor score
Files withPREC BIOSCIENCES INC11UNIV KENTUCKY RES FOUND7SEARLE & CO6UNIV VIRGINIA PATENT FOUNDATION5AGOURON PHARMA4
Top patents by PatentIndex Score
76 records- 0191US11142750B2Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genomePREC BIOSCIENCES INC·Filed 2019·Granted Oct 12, 2021·3 cites·6 claims
- 0291US5945425AMethod of using (H+ /K+)ATPase inhibitors as antiviral agentsSEARLE & CO·Filed 1995·Granted Aug 31, 1999·50 cites·17 claims
- 0386US11957682B2Compounds and methods for regulating, limiting, or inhibiting AVIL expressionUNIV VIRGINIA PATENT FOUNDATION·Filed 2022·Granted Apr 16, 2024·1 cites·19 claims
- 0484US2024035011A1Optimized engineered meganucleases having specificity for a recognition sequence in the hepatitis b virus genomePREC BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 0582US10633367B2Fluorine- and/or deuterium-containing compounds for treating non-small cell lung cancer and related diseasesX CUTAG THERAPEUTICS INC·Filed 2018·Granted Apr 28, 2020·3 cites·15 claims
- 0682US7151105B2Inhibitors of Hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the sameAGOURON PHARMA·Filed 2005·Granted Dec 19, 2006·6 cites·22 claims
- 0779US11786554B2Optimized engineered nucleases having specificity for the human T cell receptor alpha constant region genePREC BIOSCIENCES INC·Filed 2019·Granted Oct 17, 2023·1 cites·5 claims
- 0878US11788077B2Polynucleotides encoding optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genomePREC BIOSCIENCES INC·Filed 2021·Granted Oct 17, 2023·0 cites·12 claims
- 0978US10590417B2RNA ligand-displaying exosomes for specific delivery of therapeutics to cell by RNA nanotechnologyOHIO STATE INNOVATION FOUNDATION·Filed 2018·Granted Mar 17, 2020·2 cites·18 claims
- 1077US11369608B2Compounds and methods for regulating, limiting, or inhibiting AVIL expressionUNIV VIRGINIA PATENT FOUNDATION·Filed 2018·Granted Jun 28, 2022·1 cites·18 claims
- 1176US7622605B2Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the samePFIZER·Filed 2006·Granted Nov 24, 2009·2 cites·3 claims
- 1276US2024000845A1Optimized engineered nucleases having specificity for the human t cell receptor alpha constant region genePREC BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1375US10584144B2RNA nanoparticles for brain tumor treatmentUNIV KENTUCKY RES FOUND·Filed 2016·Granted Mar 10, 2020·1 cites·27 claims
- 1474US9115377B2Amycolatopsis sp. strain and methods of using the same for vanillin productionZHENG PU·Filed 2012·Granted Aug 25, 2015·2 cites·9 claims
- 1574US8268835B2Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the sameGONZALEZ JAVIER·Filed 2009·Granted Sep 18, 2012·3 cites·12 claims
- 1673US11242532B2Self-assembled 3D RNA cage nanoparticlesOHIO STATE INNOVATION FOUNDATION·Filed 2017·Granted Feb 8, 2022·1 cites·20 claims
- 1773US6750233B2Aromatic sulfone hydroxamic acid metalloprotease inhibitorPHARMACIA CORP·Filed 2001·Granted Jun 15, 2004·6 cites·103 claims
- 1873US6380189B12-amino benzoxazinones for the treatment of viral infectionsSEARLE & CO·Filed 2000·Granted Apr 30, 2002·6 cites·10 claims
- 1972US2025171757A1Optimized engineered meganucleases having specificity for a recognition sequence in the hepatitis b virus genomePREC BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 2071US2023340434A1Optimization of engineered meganucleases for recognition sequencesPREC BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 2169US11085044B2miRNA for treatment of breast cancerUNIV KENTUCKY RES FOUND·Filed 2016·Granted Aug 10, 2021·1 cites·34 claims
- 2266US11964028B2RNA nanoparticles and method of use thereofUNIV KENTUCKY RES FOUND·Filed 2020·Granted Apr 23, 2024·0 cites·26 claims
- 2366US6683077B22-Amino-benzoxazinones for the treatment of viral infectionsSEARLE & CO·Filed 2002·Granted Jan 27, 2004·2 cites·20 claims
- 2465US10351817B2Amycolatopsis sp. strain and methods of using the same for vanillin productionBGN TECH LLC·Filed 2017·Granted Jul 16, 2019·0 cites·3 claims
- 2565US2025100961A1Chemical entities for treating acute musculoskeletal pain, non-specific low-back pain, inflammatory arthritis related diseases and conditions, and compositions and methods thereofX CUTAG THERAPEUTICS SUZHOU LTD·Filed 2024·Application pending·0 cites
- 2664US9822335B2Amycolatopsis sp. strain and methods of using the same for vanillin productionBGN TECH LLC·Filed 2017·Granted Nov 21, 2017·0 cites·14 claims
- 2764US2022409703A1Drug for inhibiting adipose cell differentiation and insulin resistanceUNIV TSINGHUA·Filed 2022·Application pending·0 cites
- 2864US2024342310A1Ccdc7 circular rna encoded protein inhibits the progression of prostate cancer by up-regulating flrt3UNIV VIRGINIA PATENT FOUNDATION·Filed 2024·Application pending·0 cites
- 2963US11325939B2RNA nanoparticles for brain tumor treatmentUNIV KENTUCKY RES FOUND·Filed 2020·Granted May 10, 2022·0 cites·28 claims
- 3063US5985872A2-amino-benzoxazinones for the treatment of viral infectionsSEARLE & CO·Filed 1995·Granted Nov 16, 1999·8 cites·31 claims
- 3163US2025382641A1Polypeptide linkers for use in engineered meganucleasesPREC BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 3263US2022195407A1Optimization of engineered meganucleases for recognition sequencesPREC BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 3362US2025099604A1Pharmaceutical compositions comprising anti-tissue factor antibody-drug conjugatesEXELIXIS INC·Filed 2023·Application pending·0 cites
- 3462US2025333468A1Optimized engineered nucleases having specificity for the human t cell receptor alpha constant region genePREC BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 3561US11060096B2RNA-based compositions and adjuvants for prophylactic and therapeutic treatmentUNIV KENTUCKY RES FOUND·Filed 2019·Granted Jul 13, 2021·0 cites·13 claims
- 3660US2023183664A1Self-limiting viral vectors encoding nucleasesPREC BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 3759US9758759B2Amycolatopsis sp. strain and methods of using the same for vanillin productionBGN TECH LLC·Filed 2015·Granted Sep 12, 2017·0 cites·2 claims
- 3859US6087359AThioaryl sulfonamide hydroxamic acid compoundsFiled 1998·Granted Jul 11, 2000·7 cites·19 claims
- 3959US2023364087A1Therapeutic targeting of activated avil-induced sarcomasUNIV VIRGINIA PATENT FOUNDATION·Filed 2023·Application pending·0 cites
- 4058US10828381B2RNA nanoparticles and method of use thereofUNIV KENTUCKY RES FOUND·Filed 2016·Granted Nov 10, 2020·0 cites·22 claims
- 4158US7473790B2Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the samePFIZER·Filed 2006·Granted Jan 6, 2009·0 cites·18 claims
- 4258US2024181073A1Antibody-Drug Conjugates Comprising an Anti-BCMA AntibodySORRENTO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4358US2024082415A1Antibody-drug conjugates (adcs) comprising an anti-trop-2 antibody, compositions comprising such adcs, as well as methods of making and using the sameLEVENA SUZHOU BIOPHARMA CO LTD·Filed 2022·Application pending·0 cites
- 4455US7148226B2Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the sameAGOURON PHARMA·Filed 2003·Granted Dec 12, 2006·0 cites·28 claims
- 4555US2004097487A1Aromatic sulfonyl alpha-cycloamino hydroxamic acid compoundsSEARLE & CO·Filed 2003·Application pending·0 cites
- 4655US2024166650A1Synthetic methods and intermediates for producing compounds for treating kit- and pdgfra-mediated diseasesBLUEPRINT MEDICINES CORP·Filed 2022·Application pending·0 cites
- 4754US2004224960A1Pharmaceutical compositions and methods for their useAGOURON PHARMA·Filed 2004·Application pending·0 cites
- 4852US10519157B2Deuterated compounds for treating Fabry, Gaucher, Parkinson's and related diseases and conditions, and compositions and methods thereofX CUTAG THERAPEUTICS INC·Filed 2019·Granted Dec 31, 2019·0 cites·3 claims
- 4951US2005032793A12-amino-benzoxazinones for the treatment of viral infectionsSEARLE & CO·Filed 2003·Application pending·0 cites
- 5050US7115658B2Inhibitors of hepatitis C virus RNA-dependent RNA polymeraseAGOURON PHARMA·Filed 2003·Granted Oct 3, 2006·0 cites·2 claims
Showing the top 50 of 76 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Hui Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →